MUBFX
Price
$38.29
Change
+$0.13 (+0.34%)
Updated
Jul 31 closing price
Net Assets
902.54M
RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
Interact to see
Advertisement

MUBFX vs RMEBX

MUBFX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
MUBFX vs. RMEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MUBFX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. MUBFX (903M). MUBFX pays higher dividends than RMEBX: MUBFX (1.37) vs RMEBX (0.99). MUBFX was incepted earlier than RMEBX: MUBFX (56 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than MUBFX (0.77). MUBFX is a more actively managed with annual turnover of: 43.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than MUBFX: RMEBX (250) vs MUBFX (1000000). MUBFX annual gain was more profitable for investors over the last year : 16.24 vs. RMEBX (8.96). RMEBX return over 5 years is better than : 36.13 vs. MUBFX (-25.48).
MUBFXRMEBXMUBFX / RMEBX
Total Expense Ratio0.701.0765%
Annual Report Gross Expense Ratio0.771.0772%
Fund Existence56 years12 years-
Gain YTD12.6849.416135%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets903M118B1%
Annual Yield % from dividends1.370.99138%
Returns for 1 year16.248.96181%
Returns for 3 years30.2532.6393%
Returns for 5 years-25.4836.13-71%
Returns for 10 years11.7790.6413%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A